Top 10 Pharma Selects TrueMed for Advanced Counterfeit Drug Investigations

HELSINKI, Oct. 29, 2024 /PRNewswire/ — TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership with a Top 10 global pharmaceutical company to bolster the integrity of its medications. This strategic collaboration will harness TrueMed’s cutting-edge AI technology to protect patients from the growing threat of counterfeit and illicit medicines, while also enhancing the pharmaceutical company’s field authentication and forensic capabilities.

As counterfeit pharmaceutical volumes rise, and security professionals face increasing challenges in authenticating diverse types of packaging across various field environments, this partnership addresses critical needs. By leveraging TrueMed’s AI-powered platform, the pharmaceutical company significantly reduces reaction times during investigations, improves authentication accuracy in the field, and gathers critical forensic intelligence to support enforcement actions.

TrueMed’s AI technology uses mobile phone cameras, machine learning, and data analytics to quickly analyze packaging, identifying counterfeit drugs and verifying authenticity in seconds.

Jyrki Berg, CEO of TrueMed, remarks, “This partnership brings real change. By applying our forensic capabilities, we’re improving how counterfeit drug analysis is done, helping to make the pharmaceutical supply chain safer and more dependable.”

For more information about TrueMed’s advanced AI-counterfeit detection solutions, please visit www.truemedinc.com.

About TrueMed

TrueMed is a leading provider of anti-counterfeiting technology solutions. The company’s AI-enabled platform uses cutting-edge technology to analyze and identify potential illicit products, allowing companies to quickly and efficiently protect their brands and their customers.

For more information, please visit truemedinc.com.
Contact: Tuomas Kannas, TrueMed, 385565@email4pr.com, +358 50 568 0782

View original content to download multimedia:https://www.prnewswire.com/news-releases/top-10-pharma-selects-truemed-for-advanced-counterfeit-drug-investigations-302289590.html

SOURCE TrueMed

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

7 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

7 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago